Document Detail


Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study.
MedLine Citation:
PMID:  18055006     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To prospectively identify combined PET/CT predictors of incomplete/suboptimal primary cytoreduction in advanced ovarian cancer. METHODS: From September 2004 to March 2007, 179 patients with a Risk of Malignancy Index (RMI) >150 based on serum CA-125, ultrasound examinations and menopausal state, underwent PET/CT within 2 weeks prior to standard surgery/debulking of a pelvic tumor. Ten PET/CT features were identified and evaluated as predictors of cytoreduction in 54 patients with advanced ovarian cancer. RESULTS: Complete cytoreduction (no macroscopic residual disease) was achieved in 35% and optimal cytoreduction (<1 cm residual disease) was achieved in 56%. Using univariate analysis, predictors of incomplete cytoreduction were large bowel mesentery implants (LBMI) (P<0.003), pleural effusion (P<0.009), ascites (P<0.009) and peritoneal carcinosis (P<0.01). LBMI (P<0.03) and ascites (P<0.05) were also predictors of suboptimal cytoreduction. Using multivariate analysis, LBMI was the only independent predictor of incomplete cytoreduction (P=0.004) and no predictor of suboptimal cytoreduction was found. CONCLUSION: PET/CT predictors of cytoreduction were found. But they should not be used to withhold patients form primary cytoreductive surgery. We suggest PET/CT as a supplementary image modality prior to surgery in primary OC patients whenever accurate and comprehensive preoperative evaluation of primary tumor and metastases is desired.
Authors:
S Risum; C Høgdall; A Loft; A K Berthelsen; E Høgdall; L Nedergaard; L Lundvall; S A Engelholm
Related Documents :
8306836 - Positron emission tomography for preoperative staging of colorectal carcinoma.
9275976 - Imaging approach to staging of renal cell carcinoma.
17563906 - Clinical impact of, and prognostic stratification by, f-18 fdg pet/ct in head and neck ...
17620286 - Role of radiologic imaging at the time of initial diagnosis of stage t1b-t3b melanoma.
10555676 - Musculoskeletal infections: us manifestations.
11901036 - Catheter-based endomyocardial injection with real-time magnetic resonance imaging.
Publication Detail:
Type:  Journal Article     Date:  2007-12-04
Journal Detail:
Title:  Gynecologic oncology     Volume:  108     ISSN:  1095-6859     ISO Abbreviation:  Gynecol. Oncol.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-05     Completed Date:  2008-02-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0365304     Medline TA:  Gynecol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  265-70     Citation Subset:  IM    
Affiliation:
Department of Oncology, The Finsen Center, Rigshospitalet, Copenhagen University Hospital, Denmark. signerisum@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / diagnosis*,  pathology,  radionuclide imaging,  surgery*
Adult
Aged
Aged, 80 and over
Female
Fluorodeoxyglucose F18 / diagnostic use
Humans
Middle Aged
Neoplasm Staging
Ovarian Neoplasms / diagnosis*,  pathology,  radionuclide imaging,  surgery*
Positron-Emission Tomography
Predictive Value of Tests
Prospective Studies
Radiopharmaceuticals / diagnostic use
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypox...
Next Document:  Transtheoretical model-based multiple behavior intervention for weight management: effectiveness on ...